IDEX IDEX BIOMETRICS ASA

IDEX Biometrics ASA: Listing of Warrants – 12 Dec 2024

IDEX Biometrics ASA: Listing of Warrants – 12 Dec 2024

Reference is made to the private placement (the “Private Placement”) completed in IDEX Biometrics ASA (the “Company”) on 17 September 2024, and to the subsequent offering completed in the Company on 29 November 2024 (the “Subsequent Offering”). The subscribers in the Private Placement and the Subsequent Offering were allocated two warrants, Warrants A and Warrants B (collectively, the “Warrants”), respectively, issued by the Company for every two Offer Shares allocated to, and paid by, them in the Private Placement and the Subsequent Offering. As previously announced by the Company, the Company shall use reasonable efforts to seek to ensure that the Warrants are admitted to trading on Euronext Oslo Børs.

The Warrants will be admitted to trading on Euronext Oslo Børs on 12 December 2024.

The Warrants have already been allocated to the subscribers of the Private Placement and the Subsequent Offering and will be tradable. Warrants A will be tradable from 12 December 2024 until 7 March 2025. Warrants B will be tradable from 12 December 2024 until 7 April 2025.

Warrants A may only be exercised within the first 14 days following the Company's announcement of its Q4 2024 financial report (announcement expected on 27 February 2025, and the expected exercise period is between 28 February 2025 and 13 March 2025), and all Warrants A not exercised within such period will lapse without compensation to the holder. Warrants B may only be exercised from 31 March 2025 to 11 April 2025, and all Warrants B not exercised within such period will lapse without compensation to the holder.

Each Warrant will give the holder a right to subscribe for one new share in the Company at a subscription price of NOK 0.15. The Warrants are expected to have an economic value.

For more information relating to the Warrants, please refer to the Prospectus approved and published by the Company on 13 November 2024.

For further information contact:

Marianne Bøe, Head of Investor Relations

Kristian Flaten, CFO

E-mail:

Tel:

About IDEX Biometrics

IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit ()

About this notice:

This notice was issued by Marianne Bøe, Head of Investor Relations, on 12 December 2024 at 07:30 CET on behalf of IDEX Biometrics ASA. This information is subject to the disclosure requirements pursuant to the Norwegian Securities Trading Act section 5-12.



EN
12/12/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on IDEX BIOMETRICS ASA

 PRESS RELEASE

Mandatory notice of shareholding 27 August 2025

Mandatory notice of shareholding 27 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 9,40% of the shares and voting rights in IDEX. Sundt AS will hold 2,804,915 shares in IDEX. The ownership will represent 4,93% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section...

 PRESS RELEASE

IDEX Biometrics ASA: First half 2025 report

IDEX Biometrics ASA: First half 2025 report IDEX Biometrics ASA's first half 2025 report is attached to this notice. Recent highlights: Operating expenses excluding Cost of materials and Depreciation in the first six months of 2025 amounted to $5.2 million (excluding restructuring cost) compared to $10.7 million for the same period in 2024, resulting in a cost reduction of 52%, year-over-yearAt the end of the second quarter of 2025 the Company had 30 full-time equivalent staff members, a reduction of 10 full-time equivalents compared to previous quarter, and down from 59 on June 30, 2024....

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics - 26 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. IDEX discloses the following information on behalf of a major shareholder and primary insider. Tranche 2 of the private placement amounted to 4,359,315 shares. All shares was lent, not sold, by CEO and CFO Anders Storbråten. The shares – 4,359,315 – is now returned to Anders Storbråten. Storbråten and close relations hold 11,555,213 shares or 20,3 % shares of the tot...

 PRESS RELEASE

Mandatory disclosure of holding and notice of trade in IDEX Biometrics...

Mandatory disclosure of holding and notice of trade in IDEX Biometrics – 23 August 2025 Reference is made to IDEX Biometrics ASA's disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share, split in two tranches. IDEX discloses the following information on behalf of primary insiders. In tranche 2 of the private placement, including underwriting shares, 4,813, 857 total shares. Pinchcliffe AS, a company closely related to CEO and CFO Anders Storbråten, subscribed to 469,255 shares, ISIN NO0013536078, at NOK 3.30 per share, and Anders Storbråten, CEO and ...

 PRESS RELEASE

Mandatory notice of shareholding 22 August 2025

Mandatory notice of shareholding 22 August 2025 Reference is made to IDEX Biometrics ASA’s disclosure on 21 July 2025 of a private placement of 9,090,909 shares at NOK 3.30 per share. The Tranche 2 shares subscription andallocation have been completed on 20 August 2025. Altea AS will hold 5,347,321 shares in IDEX. The ownership will represent 10,26% of the shares and voting rights in IDEX. About this notice: The information shall be disclosed according to section 4-2 of the Norwegian Securities Trading Act (STA) and published in accordance with section 5-12 of the STA.

ResearchPool Subscriptions

Get the most out of your insights

Get in touch